Cargando…

COT-19 TREATMENT EXPERIENCE OF AND TIPS FOR ADMINISTRATING NOVO TTF

BACKGROUNDS: Current standard of care for glioblastoma, consists of postoperative temozolomide (TMZ) concomitant with radiotherapy, followed by adjuvant TMZ monotherapy. Recently, an international phase 3 trial (EF-14) demonstrated that addition of tumor-treating fields (TTF) to adjuvant TMZ after c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shimada, Daisuke, Kobayashi, Keiichi, Saito, Kuniaki, Matsumoto, Yoshie, Shiokawa, Yoshiaki, Nagane, Motoo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213441/ http://dx.doi.org/10.1093/noajnl/vdz039.199

Ejemplares similares

COT-20 PERIOPERATIVE STATUS OF SERUM D-DIMER LEVEL AND VENOUS THROMBOSIS IN PATIENTS WITH MALIGNANT BRAIN TUMOR
por: Shimada, Daisuke, et al.
Publicado: (2019)

COT-13 THE USEFULNESS OF THE CEREBRAL ANGIOGRAPHY FOR RESECTION OF THE MALIGNANT GLIOMA
por: Matsumoto, Yoshie, et al.
Publicado: (2019)

STMO-18 SUBPIAL RESECTION OF GLIOMA USING CUSA CLARITY
por: Saito, Kuniaki, et al.
Publicado: (2019)

COT-03 EVALUATING FUNCTIONING AND DISABILITY OF A PATIENT WITH BRAIN TUMOR BY WHODAS
por: Ishita, Kohei, et al.
Publicado: (2019)

BT-09 CLINICAL AND MOLECULAR GENETIC FEATURE OF CEREBELLAR GLIOBLASTOMA
por: Iijima, Shohei, et al.
Publicado: (2019)

NI-23 ULTRA-HIGH-RESOLUTION CT ANGIOGRAPHY FOR BRAIN TUMOR SURGERY
por: Saito, Kuniaki, et al.
Publicado: (2019)

STMO-14 SURGICAL MANAGEMENT OF DEEP-SEATED GLIOMA AROUND THALAMUS
por: Saito, Kuniaki, et al.
Publicado: (2019)

STMO-01 APPLICATION OF THE AMINOLEVULINIC ACID HYDROCHLORIDE FOR INTRAOPERATIVE DETECTION OF MALIGNANT BRAIN TUMORS
por: Kobayashi, Keiichi, et al.
Publicado: (2019)

ML-02 MULTIAGENT IMMUNOCHEMOTHERAPY, R-MPV-A, FOR PATIENTS WITH SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA
por: Nagane, Motoo, et al.
Publicado: (2019)

COT-23 INITIAL EXPERIENCE OF TREATMENT FOR GLIOBLASTOMA BY NOVO-TTF
por: Omura, Takaki, et al.
Publicado: (2019)

NQPC-06 FUNCTIONAL OUTCOMES OF INITIAL TREATMENTS FOR PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA ASSESSED BY ADL AND NEUROCOGNITIVE FUNCTION
por: Taku, Mikiko, et al.
Publicado: (2019)

ML-02 Chemotherapy for patients with relapsed or refractory primary CNS lymphoma
por: Nagane, Motoo, et al.
Publicado: (2020)

STMO-09 Recovery from speech deficit after injury to frontal aslant tract in glioma surgery
por: Saito, Kuniaki, et al.
Publicado: (2020)

ML-21 Tirabrutinib monotherapy for relapsed/refractory primary central nervous system lymphoma
por: Kobayashi, Keiichi, et al.
Publicado: (2020)

NQPC-07 IMMEDIATE POSTOPERATIVE REHABILITATION FOR PATIENTS WITH NEWLY-DIAGNOSED GLIOMA
por: Ikeda, Mitsuyo, et al.
Publicado: (2019)

ML-7 Liquid biopsy for MYD88 mutation in cerebrospinal fluid in patients with suspected primary CNS lymphoma
por: Yuki, Yamagishi, et al.
Publicado: (2021)

NQPC-21 QOL EVALUATION IN THE TREATMENT COURSE OF CNS LYMPHOMA
por: Yamagishi, Yuki, et al.
Publicado: (2022)

STMO-9 Maximal safe glioma resection using high resolution exoscope
por: Saito, Kuniaki, et al.
Publicado: (2021)

NQPC-5 Does high-dose methotrexate-based chemotherapy for relapsed primary CNS lymphoma increase a risk of leukoencephalopathy with prior whole brain radiotherapy?
por: Kobayashi, Keiichi, et al.
Publicado: (2021)

NQPC-03 PROGNOSTIC SIGNIFICANCE OF QUALITY-OF-LIFE EVALUATION OVER TIME IN CLINICAL PRACTICE FOR PATIENTS WITH GLIOBLASTOMA
por: Yamagishi, Yuki, et al.
Publicado: (2019)

ML-06 Diagnostic value of liquid biopsy for CNS lymphoma by detection of specific gene mutations in the cerebrospinal fluid
por: Yamagishi, Yuki, et al.
Publicado: (2020)

ML-08 Safety and efficacy of consolidation cytarabine for newly-diagnosed primary central nervous system lymphoma
por: Sasaki, Nobuyoshi, et al.
Publicado: (2020)

ML-12 Clinical impact and management of skin-related disorders during treatment of relapsed PCNSL by tirabrutinib
por: Sasaki, Nobuyoshi, et al.
Publicado: (2021)

PATH-05. A CASE OF PILOCYTIC ASTROCYTOMA HARBORING THE FGFR1 GENE MUTATION WITH A PREDOMINANT OLIGODENDROGLIOMA-LIKE COMPONENT
por: Sasaki, Nobuyoshi, et al.
Publicado: (2020)

ML-18 High-dose chemotherapy supported by autologous stem cell transplant in relapsed and refractory primary CNS lymphoma
por: Nagane, Motoo, et al.
Publicado: (2021)

Survival in patients with glioblastoma at a first progression does not correlate with isocitrate dehydrogenase (IDH)1 gene mutation status
por: Tabei, Yusuke, et al.
Publicado: (2020)

NI-22 IMPROVED DELINEATION OF THE SUPERFICIAL CEREBRAL VENOUS SYSTEM IN BRAIN CT ANGIOGRAPHY BY ULTRAHIGH-RESOLUTION CT FOR ASSISTING BRAIN TUMOR SURGERY
por: Koyanagi, Masamichi, et al.
Publicado: (2019)

GEN-13 PAIRED MUTATIONAL ANALYSIS IN SECONDARY NERVOUS SYSTEM LYMPHOMA AND PCNSL SYSTEMIC RELAPSE REVEALS DRIVER MUTATION CANDIDATES IN THE CENTRAL NERVOUS SYSTEM
por: Sasaki, Nobuyoshi, et al.
Publicado: (2022)

COT-28 Questionnaire Survey Regarding Working Condition of the Members Belongs to the Japan Society for Neuro-Oncology (JSNO) by the Gender Equality and Diversity Committee of the JSNO, 2021
por: Fujiamaki, Takamitsu, et al.
Publicado: (2021)

Liquid biopsy of cerebrospinal fluid for MYD88 L265P mutation is useful for diagnosis of central nervous system lymphoma
por: Yamagishi, Yuki, et al.
Publicado: (2021)

COT-11 Administration of Bevacizumab for patients who failed to complete Stupp regimen after glioblastoma surgery
por: Kon, Takashi, et al.
Publicado: (2020)

IL-4 CHALLENGES FOR MANAGEMENT OF PRIMARY CNS LYMPHOMA
por: Nagane, Motoo
Publicado: (2022)

COT-20 Clinical experience with tumor-treating fields therapy for newly diagnosed glioblastoma
por: Saito, Norihiko, et al.
Publicado: (2020)

COT-06 HBV REACTIVATION DURING AND AFTER THE TREATMENT OF MALIGNANT GLIOMA WITH TEMOZOLOMIDE
por: Kanamori, Masayuki, et al.
Publicado: (2019)

COT-12 Clinical feature of end-stage glioblastomas
por: Saito, Norihiko, et al.
Publicado: (2021)

COT-18 TWO CASES OF GLIOBLASTOMA WITH ASYMPTOMATIC PULMONARY ARTERY EMBOLISM AND DEEP VEIN THROMBOSIS FROM ADMISSION TO HOSPITAL
por: Kobayashi, Yusuke, et al.
Publicado: (2019)

COT-02 TREATMENT EXPERIENCE OF PAZOPANIB FOR A CASE OF VON-HIPPEL LINDAU DISEASE
por: Hayashi, Nobuhide, et al.
Publicado: (2019)

SS-1 Therapeutic challenges for glioblastoma: Temozolomide and its issues?
por: Nagane, Motoo
Publicado: (2020)

Nimotuzumab enhances temozolomide‐induced growth suppression of glioma cells expressing mutant EGFR in vivo
por: Nitta, Yusuke, et al.
Publicado: (2016)

Frontotemporal dermoid cyst with incomplete dermal sinus tract in an adult: A case report
por: Hong, Sukwoo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_95tucckisk6dg9plc6va3vpobi